Skip to main content
Premium Trial:

Request an Annual Quote

Theranos, Walgreens Settle

Theranos and Walgreens have reached a settlement, the Wall Street Journal reports. Walgreens sued its onetime partner last November for $140 million in damages.

Theranos offered its blood-testing services through some 40 Walgreens stores, mostly in Arizona. Walgreens terminated its partnership with Theranos in June 2016 after the firm had to void a large number of lab results. That move also came on the heels of a series of Wall Street Journal articles that questioned the firm's technology and testing procedures, and after regulators uncovered deficiencies in its lab practices. Theranos shuttered its labs in October 2016 as it pivoted to commercializing technologies.

Walgreens filed suit against Theranos, alleging that the firm breached the contract between the companies. The pharmacy chain said it was seeking to recoup its investment.

The Journal reports that the two have reached a settlement of more than $25 million. It adds that Theranos told investors in June that it had $54 million left on hand and was spending $10 million a month, though said it would be reducing its burn rate. The firm sought to raise some $50 million from investors in June, though the Journal says it's unclear whether it was successful in that endeavor.

Jezebel notes that Theranos' "settlement with Walgreens may be a decimating blow to the enterprise."

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.